Trimethylangelicin reduces IL-8 transcription and potentiates CFTR function

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 300, Issue 3, 2011, Pages

  Tamanini, Anna ^a   Borgatti, Monica ^b   Finotti, Alessia ^b   Piccagli, Laura ^b   Bezzerri, Valentino ^a   Favia, Maria ^c   Guerra, Lorenzo ^c   Lampronti, Ilaria ^b   Bianchi, Nicoletta ^b   Dall'Acqua, Francesco ^d   Vedaldi, Daniela ^d   Salvador, Alessia ^d   Fabbri, Enrica ^b   Mancini, Irene ^b   Nicolis, Elena ^a   Casavola, Valeria ^c   Cabrini, Giulio ^a   Gambari, Roberto ^b  

^a UNIVERSITY HOSPITAL OF VERONA   (Italy)

^b UNIVERSITY OF FERRARA   (Italy)

^c UNIVERSITY OF BARI   (Italy)

^d UNIVERSITY OF PADOVA   (Italy)

Author keywords

Angelicin; Cystic fibrosis; Psoralens

Indexed keywords

4,4',6 TRIMETHYLANGELICIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; MESSENGER RNA; PHOSPHOPROTEIN; PROTEIN KINASE B BETA; S6 KINASE; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ARTICLE; CHLORIDE TRANSPORT; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; EPITHELIUM CELL; GENE EXPRESSION; GENE INTERACTION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA INTERACTION; PROTEIN PHOSPHORYLATION; PSEUDOMONAS AERUGINOSA; SIGNAL TRANSDUCTION;

BRONCHI; CELL LINE; CHLORIDES; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DOSE-RESPONSE RELATIONSHIP, DRUG; EPITHELIAL CELLS; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-8; NF-KAPPA B; PHOSPHOPROTEINS; PHOSPHORYLATION; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PSEUDOMONAS AERUGINOSA; PSORALENS; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TRIOXSALEN;

EID: 79955005140     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00129.2010     Document Type: Article

References (41)

1. Aboul-Enein HY, Kladna A, Kruk I, Lichszteld K, Michalska T. Effect of psoralens on Fenton-like reaction generating reactive oxygen species. Biopolymers 72: 59-68, 2003.
2. Becker MN, Sauer MS, Muhlebach MS, Hirsh AJ, Wu Q, Verghese MW, Randell SH. Cytokine secretion by cystic fibrosis airway epithelial cells. Am J Respir Crit Care Med 169: 645-653, 2004.
3. Bezzerri V, Borgatti M, Nicolis E, Lampronti I, Dechecchi MC, Mancini I, Rizzotti P, Gambari R, Cabrini G. Transcription factor oligodeoxynucleotides to NF-kappaB inhibit transcription of IL-8 in bronchial cells. Am J Respir Cell Mol Biol 39: 86-96, 2008.
4. Black HR, Yankaskas JR, Johnson LG, Noah TL. Interleukin-8 production by cystic fibrosis nasal epithelial cells after tumor necrosis factor-alpha and respiratory syncytial virus stimulation. Am J Respir Cell Mol Biol 19: 210-2151, 1998.
5. Bonfield TL, Panuska JR, Konstan MW, Hilliard KA, Hilliard JB, Ghnaim H, Berger M. Inflammatory cytokines in cystic fibrosis lungs. Am J Respir Crit Care Med 152: 2111-2118, 1995.
6. Bordin F, Dall'Acqua F, Guiotto A. Angelicins, angular analogs of psoralens: chemistry, photochemical, photobiological and phototherapeu-tic properties. Pharmacol Ther 52: 331-363, 1991.
7. Bordin F, Marzano C, Baccichetti F, Carlassare F, Vedaldi D, Fal-comer S, Lora S, Rodighiero P. Photobiological properties of 1'-thieno-4,6,4'-trimethylangelicin. Photochem Photobiol 68: 157-163, 1998.
8. Borgatti M, Bezzerri V, Mancini I, Nicolis E, Dechecchi MC, Lam-pronti I, Rizzotti P, Cabrini G, Gambari R. Induction of IL-6 gene expression in a CF bronchial epithelial cell line by Pseudomonas aeruginosa is dependent on transcription factors belonging to the Sp1 superfam-ily. Biochem Biophys Res Commun 357: 977-983, 2007.
9. Borgatti M, Lampronti I, Romanelli A, Pedone C, Saviano M, Bianchi N, Mischiati C, Gambari R. Transcription factor decoy molecules based on a peptide nucleic acid (PNA)-DNA chimera mimicking Sp1 binding sites. J Biol Chem 278: 7500-7509, 2003.
10. Borgatti M, Breda L, Cortesi R, Nastruzzi C, Romanelli A, Saviano M, Bianchi N, Mischiati C, Pedone C, Gambari R. Cationic liposomes as delivery systems for double-stranded PNA-DNA chimeras exhibiting decoy activity against NF-kappaB transcription factors. Biochem Pharmacol 64: 609-616, 2002.
11. Carpagnano GE, Barnes PJ, Geddes DM, Hodson ME, Kharitonov SA. Increased leukotriene B4 and interleukin-6 in exhaled breath condensate in cystic fibrosis. Am J Respir Crit Care Med 167: 1109-1112, 2003.
12. Chilin A, Marzano C, Guiotto A, Manzini P, Baccichetti F, Carlassare F, Bordin F. Synthesis and biological activity of (hydroxymethyl)- and (diethylaminomethyl)-benzopsoralens. J Med Chem 42: 2936-2945,1999.
13. Conconi MT, Montesi F, Parnigotto PP. Antiproliferative activity and phototoxicity of some methyl derivatives of 5-methoxypsoralen and 5-me-thoxyangelicin. Pharmacol Toxicol 82: 193-198, 1998.
14. Dalla Via L, González-Gómez JC, Pérez-Montoto LG, Santana L, Uriarte E, Marciani Magno S, Gia O. A new psoralen derivative with enlarged antiproliferative properties. Bioorg Med Chem 19: 2874-2876, 2009.
15. Dechecchi MC, Nicolis E, Bezzerri V, Vella A, Colombatti M, Assael BM, et al. MPB-07 reduces the inflammatory response to Pseudomonas aeruginosa in cystic fibrosis bronchial cells. Am J Respir Cell Mol Biol 36: 615-624, 2007.
16. Dechecchi MC, Nicolis E, Norez C, Bezzerri V, Borgatti M, Mancini I, Rizzotti P, Ribeiro CM, Gambari R, Becq F, Cabrini G. Antiinflammatory effect of miglustat in bronchial epithelial cells. J Cyst Fibros 7: 555-565, 2008.
17. Devor DC, Singh AK, Bridges RJ, Frizzell RA. Psoralens: novel modulators of Cl~ secretion. Am J Physiol Cell Physiol 272: C976-C988, 1997.
18. Devor DC, Schultz BD. Ibuprofen inhibits cystic fibrosis transmembrane conductance regulator-mediated Cl~ secretion. J Clin Invest 102: 679-687, 1998.
19. DiMango E, Zar HJ, Bryan R, Prince A. Diverse Pseudomonas aeruginosa gene products stimulate respiratory epithelial cells to produce interleukin-8. J Clin Invest 96: 2204-2210, 1995.
20. + exchanger regulatory factor 1 overexpression-dependent increase of cytoskeleton organization is fundamental in the rescue of F508del cystic fibrosis transmembrane conductance regulator in human airway CFBE41o- cells. Mol Biol Cell 21: 73-86, 2010.
21. Finotti A, Treves S, Zorzato F, Gambari R, Feriotto G. Upstream stimulatory factors are involved in the P1 promoter directed transcription of the A beta H-J-J locus. BMC Mol Biol 9: 110, 2008.
22. Gambari R, Borgatti M, Bezzerri V, Nicolis E, Lampronti I, Dechecchi MC, Mancini I, Tamanini A, Cabrini G. Decoy oligodeoxyribo- nucleotides and peptide nucleic acids-DNA chimeras targeting nuclear factor kappa-B: inhibition of IL-8 gene expression in cystic fibrosis cells infected with Pseudomonas aeruginosa. Biochem Pharmacol 80: 1887-1894, 2010.
23. Guiotto A, Rodighiero P, Manzini P, et al. 6-Methylangelicins: a new series of potential photochemotherapeutic agents for the treatment of psoriasis. J Med Chem 27: 959-967, 1984.
24. Jones AM, Martin L, Bright-Thomas RJ, Dodd ME, McDowell A, Moffitt KL, Elborn JS, Webb AK. Inflammatory markers in cystic fibrosis patients with transmissible Pseudomonas aeruginosa. Eur Respir J 22: 503-506, 2003.
25. Koehler DR, Downey GP, Sweezey NB, Tanswell AK, Hu J. Lung inflammation as a therapeutic target in cystic fibrosis. Am J Respir Cell Mol Biol 31: 377-381, 2004.
26. Komura J, Ikehata H, Hosoi Y, Riggs AD, Ono T. Mapping psoralen cross-links at the nucleotide level in mammalian cells: suppression of cross-linking at transcription factor- or nucleosome-binding sites. Biochemistry 40: 4096-4105, 2001.
27. Kube DM, Fletcher D, Davis PB. Relation of exaggerated cytokine responses of CF airway epithelial cells to PAO1 adherence. Respir Res 6: 69, 2005.
28. Ma T, Tiagarajah JR, Yang H, Sonawane ND, Folli C, Galietta LJ, Verkman AS. Thiazolidinone CFTR inhibitor identified by high-throughput screening blocks cholera toxi-induced intestinal fluid secretion. J Clin Invest 110: 1651-1658, 2002.
29. Marzano C, Caffieri S, Fossa P, Bordin F. Activity of 3-carbethoxyan-gelicin photolysis products. J Photochem Photobiol B 38: 189-195, 1997.
30. Mosti L, Lo Presti E, Menozzi G, Marzano C, Baccichetti F, Falcone G, Filippelli W, Piucci B. Synthesis of angelicin heteroanalogues: preliminary photobiological and pharmacological studies. Farmaco 53: 602-610, 1998.
31. Nicolis E, Lampronti I, Dechecchi MC, Borgatti M, Tamanini A, Bianchi N, Bezzerri V, Mancini I, Giri MG, Rizzotti P, Gambari R, Cabrini G. Pyrogallol, an active compound from the medicinal plant Emblica officinalis, regulates expression of pro-inflammatory genes in bronchial epithelial cells. Int Immunopharmacol 8: 1672-1680, 2008.
32. Nicolis E, Lampronti I, Dechecchi MC, Borgatti M, Tamanini A, Bezzerri V, Bianchi N, Mazzon M, Mancini I, Giri MG, Rizzotti P, Gambari R, Cabrini G. Modulation of expression of IL-8 gene in bronchial epithelial cells by 5-methoxypsoralen. Int Immunopharmacol 9: 1411-1422, 2009.
33. Parrish JA. Phototherapy and photochemotherapy of skin diseases. J Invest Dermatol 77: 167-171, 1981.
34. Piccagli L, Borgatti M, Nicolis E, Bianchi N, Mancini I, Lampronti I, Vevaldi D, Dall'Acqua F, Cabrini G, Gambari R. Virtual screening against nuclear factor kB (NF-kB) of a focus library: identification of bioactive furocoumarin derivatives inhibiting NF-kB dependent biological functions involved in cystic fibrosis. Bioorg Med Chem 18: 8341-8349, 2010.
35. Puchelle E, De Bentzmann S, Hubeau C, Jacquot J, Gaillard D. Mechanisms involved in cystic fibrosis airway inflammation. Pediatr Pulmonol S23: 143-145, 2001.
36. Schrodinger LLC. Maestro (version 7.0.113) (Online). New York: Schrodinger, http://www.schrodinger.com [2005].
37. Stern RS. Psoralen and ultraviolet A light therapy for psoriasis. N Engl J Med 357: 682-690, 2007.
38. Vij N, Mazur S, Zeitlin PL. CFTR is a negative regulator of NFkappaB mediated innate immune response. PLoS One 4: e4664, 2009.
39. Welsh MJ, Tsui LC, Boat TF, Beaudet AL. Cystic fibrosis. In: The Metabolic and Molecular Bases of Inherited Disease, edited by Scriver CR, Beaudet AL, Sly WS, Valle D. New York, McGraw-Hill, 1995, p. 3799-3876.
40. Xu LN, Na WL, Liu X, Hou SG, Lin S, Yang H, Ma TH. Identification of natural coumarin compounds that rescue defective DeltaF508-CFTR chloride channel gating. Clin Exp Pharmacol Physiol 35: 878-883, 2008.
41. Zabner Karp P J, Seiler M, Phillips SL, Mitchell CJ, Saavedra M, Welsh M, Klingelhutz AJ. Development of cystic fibrosis and noncystic fibrosis airway cell lines. Am J Physiol Lung Cell Mol Physiol 284: L844-L854, 2003.